Unknown PHASE3 INTERVENTIONAL 2-arm NCT01593306

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

Sponsor: Indira Gandhi Medical College, Shimla

Interventions Cisplatin Paclitaxel, Cisplatin

Updated 6 times since 2017 Last updated: May 7, 2012 Started: Jul 31, 2011 Primary completion: Oct 31, 2012 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Carcinoma Cervix and is currently ongoing. Indira Gandhi Medical College, Shimla leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Nov 2019 — Jan 2021 [monthly]

Unknown Status PHASE3
Jun 2018 — Nov 2019 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indira Gandhi Medical College, Shimla

Data source: Indira Gandhi Medical College, Shimla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shimla, India